You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Global mistrust could threaten, limit coronavirus vaccine rollout: Survey

Waning trust in governments is threatening to limit the rollout of coronavirus vaccines around the world, particularly in the US, according to a survey conducted by communications firm Edelman.

Coronavirus | Coronavirus Tests | Coronavirus Vaccine

AP  |  Washington 

Coronavirus, vaccine, covid, drugs, clinical trials

Waning trust in governments and all types of media is threatening to limit the rollout of vaccines around the world, particularly in the US, according to a survey conducted by communications firm Edelman.

In an annual assessment on the state of trust in institutions, the firm found that this infodemic is breeding mistrust that could make longer the path out from the pandemic.

"This is the era of information bankruptcy, said Richard Edelman, CEO of Edelman.

He said last week's storming of the Capitol building in Washington and the fact that only a third of people are willing to get a COVID-19 vaccine straight away crystallise the dangers of misinformation".

The firm found scepticism over vaccines remains a major hurdle for their successful rollout. Across the 28 countries assessed, it found that as of November only a little below two-thirds of respondents said they would be willing to take the vaccine within a year.

That hesitancy was most prevalent in Russia, with just 15% of people surveyed willing to get vaccinated as soon as possible and only a further 25% comfortable with the idea of doing so within a year.

In the US, it found a total of 59% of people were willing to get vaccinated within a year with just 33% happy to do so as soon as possible. The highest levels of trust were recorded in India, with 51% looking forward to taking up the vaccine opportunity immediately and a further 29% within a year, for a total of 80%.

Governments and health practitioners around the world will be hoping that sceptics will be won over by a smooth rollout of the vaccines. Britain became last month the first country to approve for use the vaccine created by American pharmaceutical company Pfizer and German company BioNTech. Other countries have started using it too while other vaccines have also been authorised.

Despite the seeming hesitancy over vaccines, Edelman found that businesses have emerged as the most trusted institution partly because of the speed at which they proactively developed vaccines in record time. Also boosting trust has been their ability to find ways to work during the restrictions.

Business is trusted by some 61% of respondents, replacing the government in top spot, which fell from its mid-year top spot and is currently at 53%.

The events of this past year reinforced business' responsibility to lead on societal issues such as upskilling workers and racial justice, said Edelman.

The firm found that trust in governments has fallen sharply since the middle of 2020 when people rallied around their politicians in the early months of the pandemic. Since then, trust has fallen sharply, particularly in the US and China.

The online survey of over 33,000 people was conducted between October 19 and November 18. It is usually released to coincide with the gathering of elites in the Swiss ski resort of Davos for the World Economic Forum. This year's gathering has been cancelled because of the pandemic but the organisers are hosting online discussions from January 25-29.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, January 13 2021. 16:31 IST